CDKN1A and lung cancer: Romidepsin and SAHA increased histone and tubulin acetylation, downregulated the expression of cdc2 and cyclin B1, reduced the level of phosphorylated Rb (p-Rb), and increased p21 expression, and these changes led to G2/M arrest in breast and lung cancer cell lines [41].